Jody A. Charnow

Editor

Jody A. Charnow has been the editor of Renal & Urology News, a publication of Haymarket Media, since 2003. Previously, he had served as editor of Internal Medicine World Report and a managing editor for Medical Tribune. He holds a BA in biology from the State University of New York at Albany.

All articles by Jody A. Charnow

Key 2015 Studies Provide Insight into Resistant Hypertension

General Endocrinology

Study Does Not Support Population-Based CKD Screening

Jody A. Charnow

October 21, 2021

Case finding is more effective than population-based screening at identifying individuals with chronic kidney disease.

Bone Metabolism

Urate-Lowering Therapy Associated With Decreased Gout Flare Risk

Jody A. Charnow

August 12, 2021

Patients with asymptomatic hyperuricemia who achieved serum uric acid levels of 6.0 mg/dL or less while on urate-lowering therapy had fewer gout flare episodes, a study found.

Type 2 Diabetes

High Oxalate Increases Cardiovascular Risks in Diabetics on Hemodialysis

Jody A. Charnow

August 9, 2021

Elevated levels of serum oxalate in patients with type 2 diabetes on HD increase their risk for sudden cardiac death and other serious CV events.

Vegetables Prostate Cancer Prevention Diet

General Endocrinology

Healthy Plant-Based Diet Linked to Lower Risk for Elevated PSA

Jody A. Charnow

August 6, 2021

Finding from a recent study could be used in patient counseling to promote healthier lifestyle choices to reduce the likelihood of prostate biopsy, according to investigators.

coronary artery calcification illustration

Bone Metabolism

Serious Cardiovascular Events Linked to Low BMD in the CKD Population

Jody A. Charnow

August 5, 2021

Lowest vs highest tertile of total hip BMD was significantly associated with a 2.2-fold increased risk for major adverse cardiovascular events, study finds.

Biomarkers Help Distinguish Prostate Cancer from Prostatitis

Cardiovascular and Metabolic Disorders

Hyperuricemia Increases Risks for Cardiovascular, All-Cause Mortality

Jody A. Charnow

July 29, 2021

Each 1 mg/dL rise in uric acid level was significantly associated with a 21% and 10% increased risk for cardiovascular and all-cause mortality, respectively, a study found.

Androgen and Reproductive Disorders

COVID-19 Is Associated With Low Testosterone in Men

Jody A. Charnow

July 15, 2021

Study reveals that almost 90% of men have hypogonadism at the time of hospital admission for COVID-19.

Obesity

Obesity Linked to Lower Death Risk in mCRPC

Jody A. Charnow

July 13, 2021

Obesity in men with metastatic castration-resistant prostate cancer is associated with decreased risks for all-cause and cancer-specific mortality compared with overweight and normal-weight men.

Diabetes

Metformin Possibly Beneficial in Advanced Prostate Cancer

Jody A. Charnow

July 2, 2021

In a randomized controlled study, adding metformin to androgen deprivation therapy for low-tumor-volume metastatic hormone-sensitive prostate cancer significantly delayed development of castration-resistant disease.

Prehypertension in Pregnancy Predicts Metabolic Syndrome

Diabetes

Gestational Diabetes Followed by Type 2 Diabetes Ups CKD, ESKD Risk

Jody A. Charnow

June 15, 2021

In a study of Swedish women, gestational diabetes that progressed to type 2 diabetes was significantly associated with increased risks for chronic kidney disease and end-stage kidney disease.

Next post in Diabetes